Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03960658 · ClinicalTrials.gov registry record · Phase 1
Ketamine and Prolonged Exposure in PTSD
A Phase 1 study, sponsored by Minneapolis Veterans Affairs Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT03960658 is a Phase 1 study that has completed, run by Minneapolis Veterans Affairs Medical Center. The registered enrollment target is 12 participants.
The verdict
NCT03960658, a Phase 1 study, has completed, sponsored by Minneapolis Veterans Affairs Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
This study aims at investigating the effectiveness of the drug, Ketamine, in combination with Prolonged Exposure (PE) therapy for people suffering from PTSD. Participation in the study includes Ketamine infusions, which occur once a week for three weeks. PE therapy sessions will be scheduled one day after each infusion, and may continue up to 12 weeks. After completely therapy, there will be two monthly follow-up assessment visits.
Interventions
- DRUG ketamine-enhanced prolonged exposure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2019-04-03 |
| Est. Completion | 2019-12-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03960658
The ClinicalTrials.gov registry entry for NCT03960658 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Minneapolis Veterans Affairs Medical Center, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ketamine-enhanced prolonged exposure is the first listed.
NCT03960658 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03960658 about?
NCT03960658 is a clinical study titled "Ketamine and Prolonged Exposure in PTSD". This study aims at investigating the effectiveness of the drug, Ketamine, in combination with Prolonged Exposure (PE) therapy for people suffering from PTSD. Participation in the study includes Ketamine infusions, which occur once a week for three weeks. PE therapy sessions will be scheduled one day...
What is the current status of trial NCT03960658?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2019-04-03. Estimated completion is 2019-12-04.
What interventions are being tested in trial NCT03960658?
The interventions under investigation include: ketamine-enhanced prolonged exposure (DRUG).
Who is sponsoring clinical trial NCT03960658?
This trial is sponsored by Minneapolis Veterans Affairs Medical Center, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.